Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus remifentanil added to thiopental for ECT in adults with mood disorder
IRCT20141209020258N90Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in affective disorder comparing Dexmedetomidine + thiopental with Remifentanil + thiopental (2 arms). Primary endpoints: Blood pressure, Heart rate and 4 more. Started Apr 2018; status: completed.
02
Drugs
dexmedetomidineremifentanilthiopental
03
Conditions
affective disorder
Beyond the preview
Go deeper on IRCT20141209020258N90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N90.